A 68-year-old male with COPD on home oxygen presents to the emergency department with acute exacerbation of bronchiectasis. Sputum culture grows Pseudomonas aeruginosa sensitive to piperacillin-tazobactam, ceftazidime, fluoroquinolones, and aminoglycosides but resistant to carbapenems. Chest X-ray shows bilateral bronchial wall thickening and bronchiectatic changes. What is the most appropriate next step in management?

Question

Accepted Answer

D. Initiate combination therapy with ceftazidime 2 g IV 8-hourly plus tobramycin 5–7 mg/kg IV daily. ## Clinical Context
The patient has a documented Pseudomonas aeruginosa infection with a known resistance pattern. The organism is resistant to carbapenems (meropenem), which rules out that class despite its broad spectrum.

## Rationale for Combination Therapy

**Key Point:** Pseudomonas aeruginosa respiratory infections in bronchiectasis require combination therapy to prevent resistance emergence and ensure adequate lung penetration.

**High-Yield:** Ceftazidime (anti-pseudomonal 3rd-generation cephalosporin) + aminoglycoside (tobramycin) is the gold-standard combination for P. aeruginosa lower respiratory tract infections. This synergistic pairing:
- Ceftazidime provides beta-lactam coverage with good lung penetration
- Tobramycin (aminoglycoside) achieves high concentration in respiratory secretions and provides synergy
- Combination reduces risk of resistance development during therapy

**Clinical Pearl:** In chronic respiratory P. aeruginosa infections (bronchiectasis, cystic fibrosis), monotherapy with fluoroquinolones alone is inadequate despite in vitro susceptibility. Resistance emerges rapidly, and clinical failure rates are higher.

## Why Combination Over Monotherapy

| Factor | Ceftazidime + Tobramycin | Ciprofloxacin monotherapy |
|--------|--------------------------|-------------------------|
| Synergy | Yes (beta-lactam + AG) | No |
| Lung penetration | Excellent | Good |
| Resistance risk | Low with combination | High in chronic infection |
| Standard of care | Yes (guideline-recommended) | No for respiratory P. aeruginosa |

**Mnemonic:** **PRAT** — Pseudomonas Respiratory Aeruginosa Treatment = Piperacillin-tazobactam, Ceftazidime, or Carbapenems (if susceptible) + Aminoglycoside or Fluoroquinolone (but AG preferred for synergy).

Answer

A. Observe with supportive care and repeat sputum culture in 48 hours before starting antibiotics

Answer

B. Administer ciprofloxacin 750 mg orally twice daily as monotherapy

Answer

C. Start meropenem 1 g IV 8-hourly as empirical therapy pending culture confirmation

Explanation

Practice similar questions